Home › Hidradenitis Suppurativa › Illinois › Evanston
Hidradenitis Suppurativa clinical trials in Evanston, IL
3 studies for Hidradenitis Suppurativa are looking for participants at sites in and around Evanston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
RecruitingPhase 3
- Endeavor Health, Glenview · 5 mi away
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
RecruitingPhase 2
- NorthShore University Health System - Endeavor Health Medical Group - Skokie - Woods Drive- Site Number : 8400019, Skokie · 2 mi away
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
RecruitingPhase 2
- Endeavor Health Medical Group, Skokie · 2 mi away
About Hidradenitis Suppurativa
Hidradenitis suppurativa (HS), or acne inversa, is a chronic skin disease. It causes painful bumps in your armpits and groin. Learn about treatment.
More about Hidradenitis Suppurativa on MedlinePlus
Hidradenitis Suppurativa trials in other cities
- Boston, MA9 studies
- Tampa, FL7 studies
- Miami, FL6 studies
- Phoenix, AZ5 studies
- Birmingham, AL5 studies
- Dallas, TX5 studies
- New York City, NY5 studies
- Santa Clarita, CA4 studies
- Philadelphia, PA4 studies
- Minneapolis, MN4 studies
- New Orleans, LA4 studies
- Durham, NC4 studies
Other studies in Evanston
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer19 studies
- Breast Cancer13 studies
- Acute Myeloid Leukemia11 studies
- Obesity11 studies
- Colorectal Cancer10 studies
- Cancer (all types)9 studies
- Overweight9 studies
- Ulcerative Colitis9 studies
- Prostate Cancer9 studies
- Crohn's Disease9 studies
- Heart Failure8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.